Balboa Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,445	Closed	-$916K	–	401
2025 Q1	$916K	Sell	1,445 -7	-0.5%	-$4.82K	0.22%	83
2024 Q4	$1.03M	Sell	1,452 -47	-3%	-$39.4K	0.24%	75
2024 Q3	$1.58M	Sell	1,499 -119	-7%	-$132K	0.39%	42
2024 Q2	$1.7M	Sell	1,618 -674	-29%	-$653K	0.45%	38
2024 Q1	$2.21M	Buy	2,292 +98	+4%	+$93.2K	0.7%	26
2023 Q4	$1.93M	Sell	2,194 -304	-12%	-$250K	0.64%	26
2023 Q3	$2.06M	Sell	2,498 -12	-0.5%	-$9.43K	0.77%	22
2023 Q2	$1.8M	Sell	2,510 -205	-8%	-$158K	0.63%	25
2023 Q1	$2.23M	Buy	2,715 +226	+9%	+$170K	0.84%	21
2022 Q4	$1.8M	Sell	2,489 -115	-4%	-$84.9K	0.81%	23
2022 Q3	$1.79M	Buy	+2,604	New	+$1.64M	0.79%	21